Revium Rx.

RVRC · OTC · SIC 2834: Pharmaceutical Preparations
7
SEC Filings
$1.67
Close 2026-03-30

Business Summary

PART I . Overview We are a pre-clinical stage biopharmaceutical company focused on the development and eventual commercialization of innovative and proprietary nanoparticle-based therapies. We focus on creating smarter, more targeted treatments that improve how medicines work in the body, with the goal of increasing effectiveness while reducing side effects. We are developing unique lipid-based platforms for a variety of potential uses, including areas with high unmet-needs such as antimicrobial...

Latest Stock Quote

RVRC 2026-03-30 $1.67 O:$1.67 H:$1.67 L:$1.67 Vol:0.0M VWAP:$1.67
origin leaf: 6045f6b933d7e79d599473c4ad44fed9288ed8fce1700a24345415efcd300e3e

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001213900-26-037573EDGAR81K words

Quarterly Reports (10-Q)

No 10-Q filings indexed.

7 total filings indexed. 6 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001839140
TickerRVRC
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1764f4d47a291ad32e6305422772e48a3f369833d7277207c0e5aa81b5b97522
parent: 015da904e593f1c41558cef54357620672a6f5f9b3dc341135bb8c54bc4ffc81
content hash: 288b596125807ca69ca04da700ab438be2c64fdc8e121b938742e0eef68e2404
signed: 2026-06-03T12:02:28.665Z
sources: 2 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf